Shanghai Pulmonary Hospital

Yangpu, Shanghai Municipality 200433

1 studies enrolling now · 2 studies all time

What they study most

COVID-19, Immunocompromised, Lower Respiratory Tract Infection, Non-Small Cell Lung Cancer, Parainfluenza

Studies at this site

• Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now